Weiss Ratings Reiterates “Sell (E+)” Rating for Abpro (NASDAQ:ABP)

Abpro (NASDAQ:ABP)‘s stock had its “sell (e+)” rating restated by analysts at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

Abpro Price Performance

NASDAQ ABP opened at $0.20 on Wednesday. Abpro has a twelve month low of $0.15 and a twelve month high of $13.00. The business’s fifty day moving average is $0.23 and its 200 day moving average is $0.24.

Abpro (NASDAQ:ABP) last announced its earnings results on Wednesday, August 13th. The company reported ($0.04) EPS for the quarter.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Abpro stock. Geode Capital Management LLC boosted its stake in shares of Abpro Holdings Inc. (NASDAQ:ABP) by 127.6% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 196,494 shares of the company’s stock after buying an additional 110,159 shares during the quarter. Geode Capital Management LLC owned approximately 0.32% of Abpro worth $42,000 as of its most recent SEC filing. Institutional investors and hedge funds own 23.30% of the company’s stock.

Abpro Company Profile

Abpro Holdings Inc is a biotechnology company. The company’s mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc, formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.